Status:
COMPLETED
MAP-IDM: Identification of Molecular Markers of Sudden Death at the Acute Phase of Myocardial Infarction
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
We propose a comparative case-control study on the 2 following groups of patients: * Cases: 500 patients with ventricular fibrillation at the acute phase of myocardial infarct, * Controls: 500 patien...
Detailed Description
The number of sudden death is estimated around 50000 in France. In most cases, these deaths are due to myocardial infarction. This complication occurs, for 70% of cases, at the patient's residence, wi...
Eligibility Criteria
Inclusion
- All patients admitted to ICU for MI and presenting the following criteria:
- Age \> 18
- Group 1 (Case) Patients with cardiac arrest and ventricular fibrillation developed up to 24 h post MI Group 2 (control) Patients with MI (no ventricular fibrillation)
- Written informed consent.
Exclusion
- No written informed consent
- Known Medical History of cardiomyopathy, including acute coronary syndrome
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
1011 Patients enrolled
Trial Details
Trial ID
NCT00859300
Start Date
December 1 2007
End Date
June 1 2015
Last Update
March 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital cardiologique
Lyon, France, 69677